A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.